Thrombin Generation among Sudanese Patients with Hematological Malignancies.
Al Qurayyāt, Saudi Arabia. In Gulf J Oncolog, 2014
UNLABELLED: Hematological malignancies can change the levels of plasma molecules involved in coagulation and fibrinolysis such as fibrinopeptide A, fibrinogen, plasminogen activator inhibitor-1 (PAI-1) and D-dimer, markers of endothelial cell integrity (soluble E-selectin, van Willebrand factor and soluble thromboembolism) and of platelet function (beta-thromboglobulin).
[Beta2-glycoprotein I polymorphism].
Tokyo, Japan. In Brain Nerve, 2008
The mean values of beta-thromboglobulin and platelet factor 4 in patients with the VL genotype were significantly higher than those with the LL genotype.
Platelet function in cutaneous diseases.
Poland. In Platelets, 2008
Responding to the variety of stimuli such as cell activation leads to the release of several mediators, including RANTES, platelet factor 4, beta-thromboglobulin, thymus and activation-regulated chemokine (TARC/CCL17), serotonin and arachidonic acid metabolites.